Insulin resistance behaves more like a dial than a switch, and most people can move that dial a long way with ordinary, repeatable habits. The marker that tracks it earliest is fasting insulin, which can drift upward for years while fasting glucose still reads perfectly normal. That is why this page is organised around what you can measure, not just what you can do.
Insulin resistance is a state in which muscle, liver and fat tissue respond less strongly to insulin, so the pancreas has to release more of it to keep blood glucose in a normal range.
Insulin has three main jobs. It tells muscle cells to pull glucose out of the blood, it tells the liver to stop producing new glucose, and it tells fat cells to stop releasing fatty acids. When those tissues respond weakly, the pancreatic beta cells compensate by secreting more insulin. For a while, that compensation works. Glucose stays normal because insulin is doing extra work in the background, which is precisely why a standard glucose test can look reassuring while the underlying physiology has already shifted.
The clinical sequence usually runs in that order. Insulin rises first, post-meal glucose excursions widen next, fasting glucose drifts up later, and hemoglobin A1c moves last. By the time A1c is clearly elevated, the compensation has been running for a long time.
One nuance worth holding onto. Fasting insulin is not a single clean signal, since the number you see reflects both how much insulin is secreted and how much the liver clears from circulation, and research has shown these are distinct physiological processes that can vary between people[1]. That is a reason to interpret insulin alongside glucose and other markers rather than on its own.
In many cases, yes, at least partly, and sometimes almost completely. Insulin sensitivity is a trainable property of tissue, not a permanent trait, and it responds to changes in activity, body composition and diet, often within weeks.
The mechanism is encouraging. A single bout of exercise increases glucose uptake into working muscle through pathways that do not depend on insulin, and that effect persists for hours afterwards. Losing visceral fat reduces the flux of fatty acids and inflammatory signals reaching the liver. Both changes make the same amount of insulin go further, which is exactly what improvement looks like on a lab report, lower fasting insulin at the same or better glucose.
It is worth being honest about limits. Some contributors are not fully modifiable, including genetics, age, pregnancy, polycystic ovary syndrome, and rarer conditions affecting fat tissue. If beta cell function has already declined significantly, the picture becomes about management as well as sensitivity. Nobody can promise an outcome, and no article can tell you where your own ceiling sits.
A better framing than reverse or not reverse is direction and distance. You are trying to move fasting insulin, glucose and body composition in a favourable direction, then hold them there. That is measurable, and it is the version of the goal you can actually act on.
It matters because elevated fasting insulin and insulin resistance are associated with cardiovascular, kidney, cognitive and cancer-related outcomes in people who do not have diabetes, not only with future diabetes risk.
A meta-analysis of cohort studies in non-diabetic adults reported associations between higher fasting insulin or insulin resistance and cardiovascular and all-cause mortality[2]. A proteome-wide Mendelian randomization study has explored biological pathways potentially linking fasting insulin to coronary artery disease, which is one approach to probing whether the relationship is causal rather than incidental[3]. Insulin resistance has also been associated with incident hypertension in general population meta-analysis[4], and elevated fasting insulin has been linked with higher risk of microalbuminuria, an early marker of kidney stress[5].
The associations extend further. A dose-response meta-analysis reported a relationship between fasting insulin and cancer-related mortality in non-diabetic adults[6], and a study in older women without diabetes examined fasting insulin levels in relation to cognitive decline[7].
Read all of that carefully. These are associations drawn from populations, not predictions about an individual, and none of them means a single result tells you what will happen to you. What they do justify is treating a persistently elevated fasting insulin as information worth acting on rather than noise to be ignored.
The practical core is fasting insulin and fasting glucose drawn together, which also lets you calculate HOMA-IR, with hemoglobin A1c and the triglyceride to HDL ratio adding useful context.
Here is what each one contributes.
Testing conditions matter more than most people expect. Insulin and glucose are drawn fasting, commonly after 8 to 12 hours without food, following your lab's specific instructions. Acute illness, a hard training session the night before, poor sleep and significant stress can all nudge a single result. FitScript tests 150+ biomarkers per year precisely because a single draw in isolation is a snapshot, not a trend.
Standard labs commonly report fasting insulin as normal across a wide band, while FitScript's optimal range sits considerably tighter at the lower end of that band.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Fasting insulin | 2 to 18 µU/mL | 2 to 5 µU/mL |
| Fasting glucose | 65 to 99 mg/dL | Not applicable here |
| Hemoglobin A1c | Below 5.7% | Not applicable here |
These are typical lab reference ranges, and they vary by laboratory, assay, age and sex. Always read your own result against the range printed on your own report. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and a value outside it is not a diagnosis of anything.
The gap between the two columns is the whole point. A fasting insulin of 15 µU/mL is inside most standard reference ranges and would usually be flagged as normal, yet it sits well above the optimal target and often accompanies normal glucose. Reference ranges describe what is common in the tested population, and in a population where metabolic dysfunction is widespread, common and optimal are not the same thing. Optimal ranges aim at where the physiology appears to work best, not at where most results fall.
That distinction is also why a reader should not interpret a single number alone. Fasting glucose, A1c, lipids, body composition and symptoms all belong in the same conversation, and that conversation belongs with a clinician who can see the whole picture.
A fasting insulin above the optimal range most often reflects compensation, meaning the pancreas is producing more insulin than average to keep glucose where it is.
Follow the observation through to meaning. The observation is a number above the optimal band. What it may reflect includes reduced insulin sensitivity in muscle and liver, excess visceral fat, a period of low physical activity, short or disrupted sleep, a high intake of refined carbohydrate and ultra-processed food, pregnancy, or conditions such as polycystic ovary syndrome. Differences in how quickly the liver clears insulin can also shift the number[1].
What it does not reflect is a diagnosis. A single elevated insulin does not mean you have diabetes, prediabetes or metabolic syndrome, all of which have specific criteria that a clinician applies using more than one data point.
The next step is almost always the same. Repeat the test under properly fasted, unstressed conditions, pair it with glucose, A1c and a lipid panel, and bring the set to a clinician who can interpret it against your history. If glucose or A1c are also outside the standard range, that combination is worth discussing with a clinician promptly rather than at your convenience.
Very low fasting insulin deserves a mention too. In a lean, active person it can simply reflect excellent sensitivity. Alongside elevated glucose, however, it points toward reduced insulin production rather than resistance, which is a different situation and needs clinical assessment.
Related: Fasting Insulin Test Cost, and What Changes the Price
The main drivers are excess visceral and ectopic fat, physical inactivity and loss of muscle mass, poor sleep, chronic stress, and a diet pattern heavy in refined carbohydrate, alcohol and ultra-processed food.
Visceral fat sits around the organs and drains directly to the liver, delivering fatty acids and inflammatory signalling that interfere with insulin signalling there. Fat stored inside the liver and muscle, sometimes called ectopic fat, appears particularly relevant, which helps explain why two people at the same weight can have very different insulin profiles. Elevated fasting insulin and abdominal obesity travel together, and research has reported that elevated fasting insulin levels are associated with increased risk of developing abdominal obesity[8], suggesting the relationship runs in both directions.
Inactivity contributes independently. Muscle is the largest site of insulin-mediated glucose disposal, so both the amount of muscle you carry and how recently it has worked affect how readily glucose leaves the bloodstream. Extended sitting reduces that disposal even in people who exercise.
Sleep restriction can impair insulin sensitivity, often within a few nights. Chronic psychological stress raises cortisol, which opposes insulin's action on the liver. Certain medications affect insulin sensitivity directly, and that is a conversation for your prescribing clinician, never a reason to stop a medication on your own.
Genetics, ethnicity, age and family history also shape the baseline. They change the starting point, not the responsiveness.
Start by changing the composition and processing of what you eat rather than chasing a single named diet, since several very different patterns improve insulin sensitivity when they reduce excess energy intake and raise food quality.
Four changes do most of the work.
Plant-forward eating is reasonably supported here. A cross-sectional analysis of national survey data found that healthier plant-based dietary patterns were associated with lower fasting insulin, while less healthful plant-based patterns were not[9]. That distinction matters, since refined grains and sugar are technically plant-based too.
Low-carbohydrate and Mediterranean-style patterns may help as well. The practical question is which one you can sustain for years, because reverting to an old pattern tends to return insulin to its old level.
Meal structure helps at the margins. Eating most of your energy earlier in the day, walking after meals, and leaving a long overnight fast all tend to reduce glucose and insulin exposure. These are refinements, not foundations. No eating pattern cures insulin resistance, and anyone selling that claim is overstating what food can do.
A combination of resistance training and aerobic work outperforms either alone, because they improve insulin sensitivity through partly different routes.
Resistance training builds and preserves muscle, which expands the tissue available to store glucose as glycogen. More capacity means a given carbohydrate load produces a smaller insulin demand. Two to four sessions per week covering the major movement patterns is a reasonable structure for most adults who have been cleared to train.
Aerobic exercise improves mitochondrial function and increases fat oxidation, and it acutely increases muscle glucose uptake through contraction-stimulated pathways that work independently of insulin. That acute effect is one reason frequency matters so much. The benefit of a session fades over roughly a day or two, so three short sessions beat one long one for insulin sensitivity, even at matched total time.
Daily movement is the underrated third component. Breaking up prolonged sitting, walking after meals, and simply accumulating more steps all improve glucose handling in ways that a single gym session does not replicate. If you train hard for an hour and sit for the remaining fifteen waking hours, you have captured only part of the available benefit.
Start from where you actually are. If you are currently sedentary, a daily walk plus two short strength sessions is a larger relative change than any advanced programme, and it is the change most likely to still be happening in six months.
More than most people assume. Even a few days of short sleep can reduce insulin sensitivity in healthy adults, which places sleep alongside diet and training rather than beneath them.
The mechanisms are plausible and several. Short sleep raises evening cortisol, increases sympathetic nervous system activity, shifts appetite hormones toward greater hunger, and reduces the drive to move the next day. Each of those pushes glucose and insulin in the same unhelpful direction. Irregular sleep timing and night shift work add a circadian mismatch, since glucose tolerance is naturally lower later in the day.
Chronic stress works through overlapping pathways. Cortisol exists partly to raise blood glucose, which is useful in an emergency and counterproductive when the emergency never ends. Stress also tends to degrade everything else, sleep quality, food choices, training consistency, so its effect compounds.
Practically, aim for a consistent sleep window with a regular wake time, treat the hour before bed as a wind-down rather than a catch-up period, and get morning light exposure to anchor the rhythm. Address snoring, witnessed pauses in breathing or heavy daytime sleepiness with a clinician, since obstructive sleep apnea is strongly linked with insulin resistance and is treatable.
For stress, the specific technique matters less than the regularity. Breathing practice, time outdoors, strength training and genuine social contact all qualify.
Fat loss is the single most reliable lever for most people with excess adiposity, and meaningful improvements in insulin sensitivity typically appear well before reaching any target weight.
The reason is that visceral and liver fat tend to mobilise early during an energy deficit, often disproportionately to total weight lost. Because those depots drive much of the hepatic insulin resistance, early fat loss frequently produces a larger metabolic improvement than the scale suggests.
Body composition matters as much as mass. Preserving muscle while losing fat keeps glucose disposal capacity intact, which is why adequate protein and resistance training belong in any fat loss approach. Weight loss that strips muscle can leave insulin sensitivity less improved than expected.
It also works in the other direction. Not everyone with a higher body weight has insulin resistance, and research in adolescents has examined how insulin resistance relates to the prevalence of what is sometimes described as metabolically healthy obesity[10]. Conversely, lean people can carry significant insulin resistance, often with liver fat or low muscle mass. This is exactly why testing beats assuming.
The method that works is the one you can sustain. Aggressive short-term deficits that end in a rebound tend to return fasting insulin to baseline, and sometimes above it.
Some may help and some do not, and every prescription option requires a licensed provider to evaluate whether it is appropriate for you.
On the supplement side, the honest summary is modest. Magnesium status, inositol (studied most in polycystic ovary syndrome), berberine and omega-3 fats may support aspects of glucose and insulin metabolism, though this is uncertain and the effects are generally small next to training and fat loss. Correcting a genuine deficiency, such as low magnesium or vitamin D, is more defensible than supplementing speculatively. Supplements interact with medications, so discuss anything you plan to take with a clinician or pharmacist.
On the prescription side, several classes of glucose-lowering medication influence insulin sensitivity or glucose handling. These are not interchangeable, they have real side effect profiles and contraindications, and they are chosen based on a full clinical assessment. This page does not provide dosing, schedules or administration guidance for any prescription therapy or peptide, because those decisions belong to the licensed provider who has evaluated you in person. Peptides marketed for metabolic benefit should be treated as experimental and clinician-gated.
Nothing in this category replaces the foundations. Medication can make the physiology more forgiving while the training, nutrition and sleep work does the structural part.
Acute improvements in glucose uptake begin after a single exercise session, while a measurable change in fasting insulin usually needs several weeks to a few months of consistent change, confirmed by retesting.
The markers move on different clocks. Fasting insulin and HOMA-IR respond relatively early, since they reflect current demand on the pancreas. The triglyceride to HDL ratio tends to follow over a similar window. Hemoglobin A1c lags by design, averaging roughly three months of glucose exposure, so retesting it too soon shows you very little. Body composition and waist measurement often shift before any of the bloodwork does.
A workable approach is to establish a proper fasted baseline, make specific changes you can actually describe, then retest the same panel under the same conditions after roughly three months. Same lab, same fasting duration, similar time of day, and not the morning after a brutal training session or a terrible night of sleep.
Interpret direction over precision. A fasting insulin that moves from 16 to 11 µU/mL is a real and favourable trend even though it remains above the optimal range, and that trend tells you to continue. A result that has not moved tells you something in the inputs needs changing, not that you are beyond help.
Share every retest with your clinician, who can assess the pattern alongside your history, medications and symptoms.
Fasting glucose, hemoglobin A1c, a full lipid panel including the triglyceride to HDL ratio, liver enzymes, and inflammatory and kidney markers round out the picture, with sex hormones added where relevant.
Liver enzymes such as ALT matter because fat accumulation in the liver is tightly linked with hepatic insulin resistance. High-sensitivity CRP gives a rough read on background inflammation, which travels with metabolic dysfunction. Urinary albumin is relevant given the reported association between elevated fasting insulin and microalbuminuria[5]. Uric acid and ferritin add further context in some people.
Hormonal markers deserve attention in specific situations. In women, insulin resistance intersects with androgens and sex hormone binding globulin, which is central to polycystic ovary syndrome, and fasting insulin has been examined in relation to endogenous hormones and premenopausal breast density[11]. In men, low testosterone and insulin resistance frequently co-occur. Thyroid function affects metabolic rate and belongs in the baseline picture.
The value of testing these together is pattern recognition. One borderline number means little, while elevated insulin alongside rising triglycerides, a falling HDL, a creeping ALT and an expanding waist tells a coherent story that a clinician can act on. Interpretation also needs the non-lab context, including medications, family history, sleep, training and symptoms.
Talk to a clinician whenever your fasting insulin, glucose or A1c sits outside the standard laboratory reference range, and promptly if glucose or A1c is elevated or you have symptoms.
Specific situations that warrant a conversation sooner rather than later include fasting glucose or A1c above the standard reference range, increased thirst, frequent urination, unexplained weight loss, blurred vision or recurrent infections, a strong family history of type 2 diabetes, a history of gestational diabetes, polycystic ovary syndrome, or suspected sleep apnea. Dark velvety skin patches at the neck, armpits or groin, known as acanthosis nigricans, are also worth showing to a clinician.
Bring the full set of results rather than a single number, along with your medication and supplement list and an honest description of sleep, training and food. A clinician can distinguish between a suboptimal number that calls for lifestyle work and a pattern that needs formal assessment or treatment, and only a clinician can make that call.
This page is educational and is not medical advice. Discuss your results and any treatment with a clinician or licensed provider before acting on them, and never stop or change a prescribed medication on your own.
To go deeper on the individual markers, read the biomarker pages for Fasting Insulin, fasting glucose, homa ir, hemoglobin a1c and triglyceride hdl ratio. FitScript's Metabolic + Insulin panel groups these markers in one draw, and Atlas, FitScript's AI health advisor, interprets the results in context for members.
By combining resistance and aerobic training, reducing excess body fat, improving food quality and protecting sleep, then confirming the change by retesting fasting insulin and glucose. These levers work together, since muscle is the main site of glucose disposal and visceral fat drives much of the liver's insulin resistance. Discuss your results with a clinician.
Start with a fasted baseline of insulin, glucose, A1c and lipids so you know where you stand. Then add strength training two to four times weekly, daily walking, more protein and fibre, fewer refined carbohydrates, and consistent sleep. Retest after roughly three months under the same conditions and review with a clinician.
The reliable approach is regular exercise, fat loss where excess adiposity is present, a whole-food diet built around protein and fibre, adequate sleep and stress management, tracked with fasting insulin rather than glucose alone. Improvement is usually gradual and measurable. A licensed provider evaluates whether any medication is appropriate alongside these changes.
Naturally means the foundations, movement, body composition, food quality and sleep. Healthier plant-forward eating patterns are associated with lower fasting insulin, and exercise increases muscle glucose uptake through pathways independent of insulin. Supplements play a supporting role at best. Share your plan and results with a clinician before adding anything.
Often substantially, sometimes almost completely, though nobody can promise an outcome. Results depend on how long the pattern has been present, how much beta cell function remains, genetics, age, medications and conditions such as polycystic ovary syndrome. Improvement is best judged by retested fasting insulin and glucose, interpreted by a clinician who knows your history.
Prioritise protein at every meal, fibre from whole plants, and far less ultra-processed food and liquid sugar. Several patterns work, including Mediterranean-style and lower-carbohydrate eating, provided they reduce excess energy intake and raise food quality. Sustainability matters more than the label, because reverting usually returns fasting insulin toward its previous level.
Muscle glucose uptake improves after a single exercise session, but a measurable change in fasting insulin generally needs several weeks to a few months of consistent effort. Hemoglobin A1c lags further, since it averages roughly three months of glucose exposure. Retest the same panel under the same fasted conditions to judge direction.
Typical lab reference ranges run roughly 2 to 18 µU/mL, and FitScript's optimal range is 2 to 5 µU/mL, an optimization target rather than a diagnostic cut-off. A result above the optimal band may reflect reduced insulin sensitivity, but no single value diagnoses anything. Interpret it alongside glucose, A1c and lipids with a clinician.